Consideration of Potential Drug-Drug Interactions in Selection of FDA-Approved Drugs Indicated for Prostate Cancer

Am J Ther. 2019 May/Jun;26(3):e422-e424. doi: 10.1097/MJT.0000000000000693.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Cross-Sectional Studies
  • Drug Approval
  • Drug Interactions
  • Humans
  • Male
  • Prostatic Neoplasms, Castration-Resistant / drug therapy*
  • Prostatic Neoplasms, Castration-Resistant / pathology
  • United States
  • United States Food and Drug Administration

Substances

  • Antineoplastic Agents